ALKBH5 and gastric cancer: Using Kaplan-Meier analysis (https://kmplot.com/analysis/), we observed that patients with gastric cancer who had higher ALKBH5 mRNA levels exhibited poorer progression-free survival (PFS) and overall survival (OS), especially among male patients (Figures S1B, C).